Dynamic Contrast Enhanced Ultrasound Perfusion Imaging and Clinically Significant Portal Hypertension in Patients With Liver Cirrhosis: A Feasibility Study

被引:0
|
作者
Ainora, Maria Elena
Garcovich, Matteo
Annicchiarico, Brigida Eleonora
Siciliano, Massimo
Riccardi, Laura
Pompili, Maurizio
Rapaccini, Gian Ludovico
Gasbarrini, Antonio
Zocco, Maria Assunta
机构
关键词
D O I
10.1016/S0016-5085(16)33843-4
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Mo1539
引用
收藏
页码:S1139 / S1139
页数:1
相关论文
共 50 条
  • [1] DYNAMIC CONTRAST ENHANCED ULTRASOUND PERFUSION IMAGING AND CLINICALLY SIGNIFICANT PORTAL HYPERTENSION IN PATIENTS WITH LIVER CIRRHOSIS: A FEASIBILITY STUDY
    Ainora, M. E.
    Garcovich, M.
    Annicchiarico, B. E.
    Siciliano, M.
    Riccardi, L.
    Pompili, M.
    Rapaccini, G. L.
    Gasbarrini, A.
    Zocco, M. A.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S274 - S274
  • [2] Noninvasive Evaluation of Clinically Significant Portal Hypertension in Patients with Liver Cirrhosis: The Role of Contrast-Enhanced Ultrasound Perfusion Imaging and Elastography
    Zocco, Maria Assunta
    Cintoni, Marco
    Ainora, Maria Elena
    Garcovich, Matteo
    Lupascu, Andrea
    Iezzi, Roberto
    Annichiarico, Brigida Eleonora
    Siciliano, Massimo
    Riccardi, Laura
    Rapaccini, Gian Ludovico
    Grieco, Antonio
    Pompili, Maurizio
    Gasbarrini, Antonio
    ULTRASCHALL IN DER MEDIZIN, 2023, 44 (04): : 428 - 435
  • [3] Non invasive evaluation of clinically significant portal hypertension (PH) in patients with liver cirrhosis: the role of contrast enhanced ultrasound perfusion imaging and Doppler ultrasonography
    Zocco, Maria Assunta
    Annicchiarico, Brigida E.
    Garcovich, Matteo
    Ponziani, Francesca Romana
    Tortora, Annalisa
    Barbaro, Federico
    Campanale, Mariachiara
    Cesario, Valentina
    Siciliano, Massimo
    Gasbarrini, Antonio
    HEPATOLOGY, 2012, 56 : 747A - 748A
  • [4] Flow Resistance Analysis of Clinically Significant Portal Hypertension in Patients with Liver Cirrhosis
    Wang, Yizhe
    Zhao, Luxiang
    Zheng, Zhuozhao
    Zhang, Yu
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 2022
  • [5] Von Willebrand factor predicts clinically significant portal hypertension in patients with liver cirrhosis
    Homoncik, M.
    Ferlitsch, A.
    Reiberger, T.
    Ulbrich, G.
    Gangl, A.
    Peck-Radosavljevic, M.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S114 - S115
  • [6] Clinically significant portal hypertension in chronic liver disease: Always cirrhosis?
    Rodrigues, S.
    Berzigotti, A.
    Montani, M.
    De Gottardi, A.
    Bosch, J.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S734 - S734
  • [7] Diagnostic accuracy of contrast-enhanced ultrasound for detecting clinically significant portal hypertension and severe portal hypertension in chronic liver disease: a meta-analysis
    Duan, Yayang
    Dong, Bingtian
    Li, Siyao
    Zhang, Chaoxue
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2023, 17 (05) : 489 - 497
  • [8] Noninvasive prediction of clinically significant portal hypertension and esophageal varices in patients with compensated liver cirrhosis
    Berzigotti, Annalisa
    Gilabert, Rosa
    Abraldes, Juan G.
    Nicolau, Carlos
    Bru, Concepcion
    Bosch, Jaime
    Garcia-Pagan, Juan C.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (05): : 1159 - 1167
  • [9] INDOCYANINE GREEN CLEARANCE AS A MARKER OF DECOMPENSATION AND CLINICALLY SIGNIFICANT PORTAL HYPERTENSION IN PATIENTS WITH LIVER CIRRHOSIS
    Turco, L.
    Azzaroli, F.
    Buonfiglioli, F.
    Simoni, P.
    Lisotti, A.
    Cecinato, P.
    Calvanese, C.
    Lodato, F.
    Montagnani, M.
    Golfieri, R.
    Colecchia, A.
    Festi, D.
    Mazzella, G.
    DIGESTIVE AND LIVER DISEASE, 2011, 43 : S174 - S174
  • [10] Is von Willebrand factor a predictive parameter for clinically significant portal hypertension in patients with liver cirrhosis?
    Homoncik, Monika
    Ferlitsch, Arnulf
    Ulbrich, Gregor
    Reiberger, Thomas
    Gangl, Alfred
    Peck-Radosavljevic, Markus
    HEPATOLOGY, 2007, 46 (04) : 590A - 591A